|
|
||||||||
Reviews |
Department of Women's Health, Guy's & St Thomas' Hospital, Lambeth Palace Road, London, SE1 7EH, UK. email: dattakumar.kunde{at}gstt.nhs.uk (corresponding author)
Yakoub Khalaf, MD MRCOG, Consultant Gynaecologist
Guy's & St. Thomas' Hospital, London, SE1 7EH, UK.
In recent years there has been a trend towards conservative treatment for symptomatic uterine fibroids. Historically, myomectomy has been the operation of choice. Over the past few years, however, new minimally invasive procedures have evolved. These include laparoscopic myomectomy, laparoscopic myolysis, uterine artery embolisation and, more recently, magnetic resonance-guided percutaneous laser ablation, interstitial laser photocoagulation and high-intensity focused ultrasound energy. Simultaneously, nonsurgical treatments including gonadotrophin-releasing hormone analogues and a levonorgestrel intrauterine system have been tried, with limited success. In this era of evidence-based medicine, a thorough assessment of available research data is necessary to determine the place of new therapies in clinical practice. This review discusses the various treatments and outlines a pragmatic approach to the management of fibroids in women wishing to preserve their uterus. This should enable clinicians to counsel women regarding the most appropriate treatment option based on the specific clinical situation.
Keywords Keywords / fibroids / GnRH analogues / minimal access surgery / myomectomy / non-surgical treatment / uterine artery embolisation
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |